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Background:  Diabetic patients with coronary artery disease (CAD) demonstrate accelerated progression of coronary atherosclerosis. The impact of 
multiple risk factor intervention on disease progression has not been investigated.
Methods:  460 diabetic patients with angiographic CAD underwent serial intravascular ultrasound imaging to monitor the change in atheroma 
burden in 7 clinical trials. Disease progression was compared in patients stratified according to whether they achieved increasing numbers of 
treatment goals of individual risk factors (HbA1c<7.0%, LDL-C <100mg/dL, triglyceride<150mg/dL, systolic blood pressure <130mmHg, CRP 
<2.0mg/L).
Results:  A high rate of established medical therapies was used in all patients (89% statins, 94% aspirin, 76% `-blockers, 66% ACE inhibitors, 66% 
metformin, 62% TZD, 17% insulin). No differences were observed with regard to percent atheroma volume (PAV) and total atheroma volume (TAV) at 
baseline. On serial evaluation slowing of progression of PAV (p=0.011) and TAV (p<0.001) was observed with increasing the number of risk factors 
achieving treatment goals. On multivariable analysis adjusting for baseline risk factors, increasing the number of factors meeting treatment goals 
continued to be associated with a beneficial impact on progression of PAV (p=0.031) and TAV (p<0.001) (Table).
Conclusions:  The benefit of achieving optimal control of multiple risk factors highlights the need for modification of global risk in patients with 
diabetes.
